The official declaration means more funding for research initiatives.
President Joe Biden officially declared September 2021 as National Ovarian Cancer Awareness Month in a briefing last month.
Biden noted that his administration plans to build on the current efforts to eliminate ovarian cancer by supporting investments in research and technology to develop new ways to detect ovarian cancer early and improve treatment strategies.
Although September has been widely recognized as Ovarian Cancer Awareness Month by organizations like the Ovarian Cancer Research Alliance (OCRA), the official observation means funding for the things that matter; Biden also called for the creation of an Advanced Research Projects Agency for Health at the National Institutes of Health (NIH), known as ARPA-H, that would invest $6.5 billion to develop breakthroughs that prevent, detect, and treat cancer and other deadly diseases.1
In 2018, the latest year for which incidence data are available, 19,679 cases of ovarian cancer were reported among women.2
For every 100,000 women, 10 new ovarian cancers were reported.2
Ovarian cancer is the second most common gynecologic cancer in the United States.2
Ovarian cancer causes more deaths each year than any other gynecologic cancer in the United States.2
References
Dostarlimab shows significant survival benefits in endometrial cancer trial
March 21st 2024GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More